For instance, one study reported that increased expression of the complement system-related protein CD46 was linked to enhanced invasive characteristics of BLCA tumor cells [28], while another study pointed to the protective effects of this system in BLCA [29]. Here, CD46 is linked to bladder transitional cell carcinoma.